Showing posts with label Pharma Technologies. Show all posts
Showing posts with label Pharma Technologies. Show all posts

Thursday, December 12, 2013

TIDES 2014 Brochure Now Available

The final agenda is now available for IBC's 16th Annual TIDES conference, taking place May 12-15, 2014 in Providence, RI. TIDES provides you with the industry updates, evolving technologies, and networking opportunities needed to advance your research, development and process chemistry efforts forward. Whether your focus is in oligonucleotides or peptides, TIDES is your one-stop conference for full coverage of discovery, development and manufacturing.

Program Highlights: 

Accelerate your pipeline and improve your manufacturing operations by accessing case studies, regulatory updates and lessons learned from 100 industry and academic presentations 

Benchmark your current development efforts by hearing preclinical and clinical successes and failures from peptides and oligonucleotides currently in development 

Access novel technologies and cutting-edge science in the exhibit and poster hall, featuring over 75 exhibitors and 30 peer-submitted posters 

Forge scientific and business partnerships by meeting 750 global oligonucleotide and peptide professionals during networking luncheons, cocktail receptions and refreshment breaks 

To learn more, download our brochure

First time attendees receive 20% off of the standard rate with code XB14180BLOG, register today!. If you have questions about the event, feel free to contact our group manager, Kate Devery (Kdevery@iirusa.com), or visit our webpage. We look forward to seeing you May 12-15 in Providence, RI! 

Cheers, 
The Tides Team 

Opt-in for updates
Follow us on Twitter
Join our LinkedIn Group


Share this article with your social network, just click below to share now!


Thursday, August 27, 2009

Liquid protien could help in drug delivery

According to in-Pharma Technologies, a newly developed liquid protein, which would be the first in the world, and could help with the delivery of therapeutic proteins and high potency drugs.

Professor Stephen Mann who was incharge of the team that developed the protien stated “represents a possible way forward to a novel state of biomolecular matter, and could therefore have a number of important [biomedical] applications.”

Read the full article here.

If you'd like to network with other professionals in the drug delivery field, join our LinkedIn group! Or follow our Drug Delivery Twitter here.


Share this article with your social network, just click below to share now!